SEC Company Response from NANOVIRICIDES, INC. (NNVC) (CIK 0001379006) (NNVC) — Apr 3, 2007

NANOVIRICIDES, INC. (NNVC) (CIK 0001379006)
Date: April 3, 2007 · CIK: 0001379006 · Accession: 0001140361-07-007041

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

Date

April 3, 2007

Author

Eugene Seymour, M.D.

Form

CORRESP

Company

NANOVIRICIDES, INC. (NNVC) (CIK 0001379006)

Letter

VIA EDGAR Securities and Exchange Commission Attention: Suzanne Hayes, Esq. Re: NanoViricides, Inc. Form 10-SB, filed November 14, 2006 File No. 0-52318

Dear Ms. Hayes:

Please be advised that the undersigned is the duly elected Chief Executive Officer of NanoViricides, Inc. (the "Registrant"). Having been advised that the Commission has no further comments to the Registrant's Form 10-SB Registration Statement, the Registrant hereby requests acceleration of the effective date of the Registration Statement to Monday, April 8, 2007 at 9:30 a.m., or as soon thereafter as practicable.

Should you have any questions in regard to this correspondence or any other matter relating to this Registrant's filing, please do not hesitate to contact me.

Very
truly yours,
/s/
Eugene Seymour, M.D.

Show Raw Text

CORRESP
1
filename1.htm

      Nanoviricides Correspondence 4-3-2007

      NANOVIRICIDES,
        INC.

      135
        Wood
        Street

      Suite
        205

      West
        Haven, Connecticut 06516

              April
                3, 2007

    VIA
      EDGAR

    AND
      FACSIMILE

    Securities
      and Exchange Commission

    100
      F
      Street, N.E.

    Mail
      Stop
      6010

    Washington,
      D.C. 20549

    Attention:
      Suzanne Hayes, Esq.

              Re:

              NanoViricides,
                Inc.

              Form
                10-SB, filed November 14, 2006

              File
                No. 0-52318

    Dear
      Ms.
      Hayes:

    Please
      be
      advised that the undersigned is the duly elected Chief Executive Officer of
      NanoViricides, Inc. (the "Registrant"). Having been advised that the Commission
      has no further comments to the Registrant's Form 10-SB Registration Statement,
      the Registrant hereby requests acceleration of the effective date of the
      Registration Statement to Monday, April 8, 2007 at 9:30 a.m., or as soon
      thereafter as practicable.

    Should
      you have any questions in regard to this correspondence or any other matter
      relating to this Registrant's filing, please do not hesitate to contact
      me.

              Very
                truly yours,

              /s/
                Eugene Seymour, M.D.

              Eugene
                Seymour, M.D.

SecProbe.io